ResearcherSecond Affiliated Hospital of Nanchang UniversityNo recent work listed

Anwen Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4012-9717; OpenAlex author ID A5101859329. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2017: 1 paper

Papers 1

USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway. Last author DOI 10.1016/j.bbrc.2017.03.025 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jing Cai · 1 shared paper, 2017 · strength 0.08
- Paper USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway. DOI 10.1016/j.bbrc.2017.03.025 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.